The Market Reports

Synopsis
The global market for Veterinary Drug was estimated to be worth US$ 26380 million in 2024 and is forecast to a readjusted size of US$ 38170 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Veterinary Drug cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The growth of the veterinary drug market is primarily driven by the rising global demand for animal protein, such as meat, milk, and eggs, which necessitates improved animal health and productivity. Increasing pet ownership and heightened awareness of animal welfare are also contributing to greater demand for preventive and therapeutic veterinary treatments. Moreover, advancements in veterinary medicine—such as targeted antibiotics, vaccines, and parasiticides—are helping to address a wide range of animal diseases more effectively. Government initiatives and regulatory support for animal healthcare further strengthen the market, especially in emerging economies with expanding livestock and pet populations.
A major challenge in the veterinary drug market is the growing concern over antimicrobial resistance (AMR) resulting from the overuse and misuse of antibiotics in animals. Regulatory authorities are imposing stricter rules on drug approvals and usage, which can increase development costs and limit market accessibility for certain products. Additionally, the high cost and lengthy process of veterinary drug development—combined with the need for specialized R&D infrastructure—pose significant barriers to entry for smaller firms. Price sensitivity in developing regions and limited access to veterinary care in rural areas also hinder market penetration, particularly for premium or innovative drug formulations.
This report aims to provide a comprehensive presentation of the global market for Veterinary Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Veterinary Drug by region & country, by Type, and by Application.
The Veterinary Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drug.
Market Segmentation
By Company
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Jinhe Bio
Qianjiang Biochemical
Segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segment by Application
Pets
Cattle
Poultry
Swine
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Veterinary Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Veterinary Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index